The previous page is sending you to http://www.newevidence.com/oncology/confirmatory-overall-survival-analysis-of-cleopatra-a-randomized-doubleblind-placebo-controlled-phase-iii-study-with-pertuzumab-trastuzumab-and-docetaxel-in-patients-with-her2-positive-first-line/.

 If you do not want to visit that page, you can return to the previous page.